Pfizer's Covid vaccine over 90% effective at keeping 12 to 18 age group out of hospital, CDC says

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
A vial of the Pfizer BioNTech vaccine for coronavirus treatment. Spain has exceeded 32 million people vaccinated with the full schedule. (Photo Illustration by Marcos del Mazo/LightRocket via Getty Images)
A vial of the Pfizer BioNTech vaccine for coronavirus treatment. Spain has exceeded 32 million people vaccinated with the full schedule. (Photo Illustration by Marcos del Mazo/LightRocket via Getty Images)
Marcos del Mazo/ contributor

The two-dose vaccine by Pfizer-BioNTech was 93% effective against hospitalisation with Covid-19 among 12 to 18-year-olds, according to an analysis released recently by the US Centers for Disease Control and Prevention (CDC).

The report, released last Tuesday, is the strongest evidence to date indicating the mRNA jab's ability to protect this age group against the severe effects of the disease.

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.
Subscribe
Already a subscriber? Sign in
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
29% - 9741 votes
No
71% - 23834 votes
Vote